Patient-Reported Outcomes from the Randomized Phase Iii Alex Study of Alectinib Versus Crizotinib in Patients with Alk-Positive Non-Small-Cell Lung Cancer
AuthID
P-00R-62M
P-00R-62M
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service